Top Regulatory News Stories – Week Ending March 16, 2018

This week the FDA granted Breakthrough Therapy status to three development programs and halted two different clinical trials.  Here are the top regulatory news stories to follow this week: Ocular Therapeutix, which had its lead drug rejected by the FDA last summer said that it remains on track to resubmit its application to the FDA[…]